Diffuse Intrinsic Pontine Glioma - 26 Studies Found
| Recruiting |
: Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma :
: 2010-04-19 |
| Completed |
: PDGFR Inhibitor Crenolanib in Children/Young Adults With Diffuse Intrinsic Pontine Glioma or Recurrent High-Grade Glioma :
|
| Active, not recruiting |
: A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas :
|
| Recruiting |
: Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines : Diffuse Intrinsic Pontine Glioma : 2016-05-31 : Biological: Autologous dendritic cells |
| Not yet recruiting |
: CED With Irinotecan Liposome Injection Using Real Time Imaging in Children With DIPG : Diffuse Intrinsic Pontine Glioma : 2017-03-16 : Drug: Convection Enhanced Delivery (CED) of Nanoliposomal irinotecan (nal-IRI) Nal-IRI will be given dir |
| Active, not recruiting |
: Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas :
: |
| Not yet recruiting |
: Re-Irradiation of Progressive or Recurrent DIPG : Recurrent or Progressive Diffuse Intrinsic Pontine Glioma : 2017-04-19 : Radiation: re-irradiation if DIPG has progressed or recurred at 180 days or later from completion of pri |
| Active, not recruiting |
: H3.3K27M Peptide Vaccine for Children With Newly Diagnosed DIPG and Other Gliomas :
: 2016-11-02 : Biological: K27M peptide K27M peptide vaccine, combined with Tetanus Toxoid peptide, emulsified in monta |
| Recruiting |
: Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma : Glioma : 2016-02-22 : Drug: LBH589 Patients with recurrent/progressive DIPG will be enrolled at the time of progression. Thera |
| Completed |
: A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas : Diffuse Intrinsic Pontine Glioma : 2002-05-10 :
|